{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:07:52Z","timestamp":1791259672362,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1093\/intimm\/dxn042","type":"journal-article","created":{"date-parts":[[2008,5,11]],"date-time":"2008-05-11T00:24:14Z","timestamp":1210465454000},"page":"841-848","source":"Crossref","is-referenced-by-count":103,"title":["Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers"],"prefix":"10.1093","volume":"20","author":[{"given":"Dario","family":"Sangiolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Martinuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Todorovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katiuscia","family":"Vitaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Vallario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noela","family":"Jordaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Carnevale-Schianca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Capaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Geuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Casorzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Aglietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cignetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,5,9]]},"reference":[{"key":"key\n\t\t\t\t20170710092947_bib1","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood.V97.10.2923","article-title":"Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production","volume":"97","author":"Baker","year":"2001","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170710092947_bib2","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.4049\/jimmunol.162.11.6410","article-title":"Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells","volume":"162","author":"Eberl","year":"1999","journal-title":"J. Immunol."},{"key":"key\n\t\t\t\t20170710092947_bib3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.4049\/jimmunol.153.4.1687","article-title":"A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency","volume":"153","author":"Lu","year":"1994","journal-title":"J. Immunol."},{"key":"key\n\t\t\t\t20170710092947_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2141.1994.tb08297.x","article-title":"Propagation of large numbers of T cells with natural killer cell markers","volume":"87","author":"Schmidt-Wolf","year":"1994","journal-title":"Br. J. Haematol"},{"key":"key\n\t\t\t\t20170710092947_bib5","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1182\/blood.V92.9.3318","article-title":"Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice","volume":"92","author":"Hoyle","year":"1998","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170710092947_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1705503","article-title":"Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation","volume":"38","author":"Introna","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"key\n\t\t\t\t20170710092947_bib7","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1158\/1078-0432.CCR-05-2019","article-title":"Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study","volume":"12","author":"Chan","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170710092947_bib8","first-page":"5785","article-title":"Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3","volume":"62","author":"Scheffold","year":"2002","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170710092947_bib9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3748\/wjg.v8.i3.464","article-title":"Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo","volume":"8","author":"Wang","year":"2002","journal-title":"World J. Gastroenterol"},{"key":"key\n\t\t\t\t20170710092947_bib10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S1083-8791(01)70014-6","article-title":"Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma","volume":"7","author":"Verneris","year":"2001","journal-title":"Biol. Blood Marrow Transplant."},{"key":"key\n\t\t\t\t20170710092947_bib11","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2003-06-2125","article-title":"Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells","volume":"103","author":"Verneris","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170710092947_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbmt.2004.11.019","article-title":"A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma","volume":"11","author":"Leemhuis","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"key\n\t\t\t\t20170710092947_bib13","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3748\/wjg.v10.i8.1146","article-title":"Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma","volume":"10","author":"Shi","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"key\n\t\t\t\t20170710092947_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/35077251","article-title":"Haematopoietic cell transplantation as immunotherapy","volume":"411","author":"Appelbaum","year":"2001","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170710092947_bib15","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2004.01.127","article-title":"Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer","volume":"22","author":"Bishop","year":"2004","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t20170710092947_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood-2003-07-2236","article-title":"Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors","volume":"103","author":"Blaise","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170710092947_bib17","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1182\/blood.V99.11.4234","article-title":"Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer","volume":"99","author":"Bregni","year":"2002","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170710092947_bib18","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1182\/blood-2005-10-3945","article-title":"Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T-cells directed to a tumor-associated antigen are generated in vivo during GVHD","volume":"107","author":"Carnevale-Schianca","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170710092947_bib19","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJM200009143431101","article-title":"Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation","volume":"343","author":"Childs","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170710092947_bib20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood-2003-07-2344","article-title":"Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning","volume":"103","author":"Bethge","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170710092947_bib21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2003-02-0342","article-title":"Graft-versus-leukemia reactions in allogeneic chimeras","volume":"103","author":"Kolb","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170710092947_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminoncol.2003.10.016","article-title":"Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy\u2014from bench to patient bedside","volume":"31","author":"Slavin","year":"2004","journal-title":"Semin. Oncol."},{"key":"key\n\t\t\t\t20170710092947_bib23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.bmt.1705393","article-title":"Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma","volume":"37","author":"van de Donk","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"key\n\t\t\t\t20170710092947_bib24","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3324\/haematol.11132","article-title":"Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study","volume":"92","author":"Introna","year":"2007","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20170710092947_bib25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1182\/blood.V108.11.412.412","article-title":"Cytokine induced killer (CIK) cells as post-transplant immunotherapy following allogeneic hematopoietic cell transplantation","volume":"108","author":"Laport","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170710092947_bib26","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V108.11.3698.3698","article-title":"Infusion of donor derived cytokine induced killer cells may induce clinical remission with limited GVHD in patients relapsing after allogeneic stem cell transplantation","volume":"108","author":"Introna","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170710092947_bib27","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.4049\/jimmunol.175.12.7819","article-title":"Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells","volume":"175","author":"Karimi","year":"2005","journal-title":"J. Immunol."},{"key":"key\n\t\t\t\t20170710092947_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35093109","article-title":"Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity","volume":"413","author":"Diefenbach","year":"2001","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170710092947_bib29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y","article-title":"Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin","volume":"31","author":"Pende","year":"2001","journal-title":"Eur. J. Immunol."}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/intimm\/article-pdf\/20\/7\/841\/18322341\/dxn042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T07:27:00Z","timestamp":1684394820000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intimm\/article-lookup\/doi\/10.1093\/intimm\/dxn042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,9]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2008,5,9]]},"published-print":{"date-parts":[[2008,7]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxn042","relation":{},"ISSN":["1460-2377","0953-8178"],"issn-type":[{"value":"1460-2377","type":"electronic"},{"value":"0953-8178","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5,9]]}}}